EQA Program
Our external quality assessment (EQA) program is aimed at medical laboratories and point-of-care testing sites. The program includes more than 250 clinically relevant external quality assessment schemes and it is compliant with ISO 15189 standard requirements.
Product catalogue 2024
Download this year's product catalogue here!
Changes in the 2025 program
New schemes and products
- 5850 Brucella antibodies
- 5241 Bordetella pertussis/parapertussis, nucleic acid detection
- 5687 HBsAg and HCVAb POCT
- 5251 Interferon Gamma Release Assay (IGRA) for Mycobacterium tuberculosis - whole blood sample
- 5686 Norovirus, antigen detection
- 2755 Holotranscobalamin (HoloTC) and Methylmalonic Acid
Planned pilot schemes
Pilot schemes are EQA schemes under our product development.
All changes are listed in the Product Catalogue on page 5.
Subscription for 2025 will open on 2 September 2024
Please subscribe to the 2025 EQA programs before the end of November 2024 to ensure your participation in all needed EQA rounds. You can renew your subscription by contacting our local partner in your country. Direct customers can renew their subscriptions on LabScala starting on 2 September 2024. If you need more information, please contact our customer service: info@labquality.com.Sales and Customer Service
Juha Wahlstedt
Jukka Korhonen
Minna Kankainen
Related Services
External Quality Assessment
Our EQA schemes are designed for medical laboratories and point-of-care testing sites to monitor and improve their performance.
Integrated EQA Service
Integrated EQA service is a completely new approach to external quality assessment.
Labquality’s Partners in EQA
Labquality has EQA partners in more than 40 countries in Europe, South America, South-East Asia and the Middle East. Please find the contact details here.
External Quality Assessment Services
Our external quality assessment service programme includes more than 160 EQA schemes, covering the key specialities of laboratory medicine.
New rounds
Labquality follows the development of laboratory medicine and produces clinically relevant EQA schemes to serve laboratories and point-of-care sites.
EQAS for preanalytical phase
Labquality’s preanalytical external quality assessment schemes provide a unique means to assess a larger part of the total laboratory testing cycle.
Latest news
Patient Safety: The Cornerstone of Healthcare
Learn how Labquality supports patient safety in healthcare through external quality assessments, clinical trials, medical device safety, and training to ensure high standards in patient care.Labquality Days 2025 program published
The scientific program for the 2025 congress has now been published!Does your device require a clinical investigation?
Clinical investigations are mandatory for certain medical devices in the EU. But how to know if your product requires a clinical study? Visit our blog to find out.Subscribe to our newsletter
Subscribe to hear the latest news in the industry and keep track of what's happening behind the scenes.